Lytic therapy in central venous catheters for hemodialysis
- PMID: 12224368
Lytic therapy in central venous catheters for hemodialysis
Abstract
Over the past 2 decades the use of central venous catheters (CVCs) for hemodialysis has become commonplace. While these devices have provided much needed temporary access to the bloodstream, they often become thrombosed and require procedures to restore patency. This article examines the lytic enzymes that are currently available and focuses on the assessment and treatment of thrombosis.
Similar articles
-
The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.Nephrol Nurs J. 2001 Aug;28(4):403-4, 407-10. Nephrol Nurs J. 2001. PMID: 12143462 Clinical Trial.
-
Does low-dose heparin maintain central venous access device patency?: a comparison of heparin versus saline during a period of heparin shortage.JPEN J Parenter Enteral Nutr. 2010 Jul-Aug;34(4):444-9. doi: 10.1177/0148607110362082. JPEN J Parenter Enteral Nutr. 2010. PMID: 20631392
-
[Case report: Direct percutaneous placement of tunneled hemodialysis catheter into the inferior vena cava in a patient with dialysis access problem].Tani Girisim Radyol. 2003 Jun;9(2):260-2. Tani Girisim Radyol. 2003. PMID: 14661499 Turkish.
-
Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.J Thromb Thrombolysis. 2001 Apr;11(2):127-36. doi: 10.1023/a:1011272632286. J Thromb Thrombolysis. 2001. PMID: 11406727
-
[Treatment of obstruction and thrombosis due to central venous catheterization].Klin Padiatr. 1991 Nov-Dec;203(6):420-3. doi: 10.1055/s-2007-1025466. Klin Padiatr. 1991. PMID: 1758144 Review. German.
Cited by
-
Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase.Ren Fail. 2018 Nov;40(1):384-389. doi: 10.1080/0886022X.2018.1487856. Ren Fail. 2018. PMID: 30010473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous